Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia.
Rensing-Ehl A, Janda A, Lorenz MR, Gladstone BP, Fuchs I, Abinun M, Albert M, Butler K, Cant A, Cseh AM, Ebinger M, Goldacker S, Hambleton S, Hebart H, Houet L, Kentouche K, Kühnle I, Lehmberg K, Mejstrikova E, Niemeyer C, Minkov M, Neth O, Dückers G, Owens S, Rösler J, Schilling FH, Schuster V, Seidel MG, Smisek P, Sukova M, Svec P, Wiesel T, Gathmann B, Schwarz K, Vach W, Ehl S, Speckmann C. Rensing-Ehl A, et al. Among authors: schilling fh. Haematologica. 2013 Dec;98(12):1948-55. doi: 10.3324/haematol.2012.081901. Epub 2013 Jul 12. Haematologica. 2013. PMID: 23850805 Free PMC article.
Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents.
Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Müller I, Suttorp M, Bernig T, Beutel K, Bode SF, Kentouche K, Kolb R, Längler A, Minkov M, Schilling FH, Schmid I, Vieth S, Ehl S, Zur Stadt U, Janka GE. Lehmberg K, et al. Among authors: schilling fh. Br J Haematol. 2015 Aug;170(4):539-49. doi: 10.1111/bjh.13462. Epub 2015 May 4. Br J Haematol. 2015. PMID: 25940575 Free article. Clinical Trial.
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification.
Berthold F, Rosswog C, Christiansen H, Frühwald M, Hemstedt N, Klingebiel T, Fröhlich B, Schilling FH, Schmid I, Simon T, Hero B, Fischer M, Ernst A. Berthold F, et al. Among authors: schilling fh. Pediatr Blood Cancer. 2021 Aug;68(8):e29038. doi: 10.1002/pbc.29038. Epub 2021 Apr 7. Pediatr Blood Cancer. 2021. PMID: 33826231
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation.
Berthold F, Ernst A, Hero B, Klingebiel T, Kremens B, Schilling FH, Simon T. Berthold F, et al. Among authors: schilling fh. Br J Cancer. 2018 Aug;119(3):282-290. doi: 10.1038/s41416-018-0169-8. Epub 2018 Jul 11. Br J Cancer. 2018. PMID: 29991700 Free PMC article. Clinical Trial.
Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR.
Berthold F, Faldum A, Ernst A, Boos J, Dilloo D, Eggert A, Fischer M, Frühwald M, Henze G, Klingebiel T, Kratz C, Kremens B, Krug B, Leuschner I, Schmidt M, Schmidt R, Schumacher-Kuckelkorn R, von Schweinitz D, Schilling FH, Theissen J, Volland R, Hero B, Simon T. Berthold F, et al. Among authors: schilling fh. Ann Oncol. 2020 Mar;31(3):422-429. doi: 10.1016/j.annonc.2019.11.011. Epub 2020 Jan 24. Ann Oncol. 2020. PMID: 32067684 Free article. Clinical Trial.
Correction: Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation.
Berthold F, Ernst A, Hero B, Klingebiel T, Kremens B, Schilling FH, Simon T. Berthold F, et al. Among authors: schilling fh. Br J Cancer. 2019 Nov;121(10):894-895. doi: 10.1038/s41416-019-0592-5. Br J Cancer. 2019. PMID: 31551583 Free PMC article.
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.
Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, Klingebiel T, Kremens B, Schilling FH, Schrappe M, Simon T, Hero B. Berthold F, et al. Among authors: schilling fh. Lancet Oncol. 2005 Sep;6(9):649-58. doi: 10.1016/S1470-2045(05)70291-6. Lancet Oncol. 2005. PMID: 16129365 Clinical Trial.
Heterogeneity of the MYCN oncogene in neuroblastoma.
Theissen J, Boensch M, Spitz R, Betts D, Stegmaier S, Christiansen H, Niggli F, Schilling F, Schwab M, Simon T, Westermann F, Berthold F, Hero B. Theissen J, et al. Clin Cancer Res. 2009 Mar 15;15(6):2085-90. doi: 10.1158/1078-0432.CCR-08-1648. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276282
71 results